Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00641680 | Rhinocort Aqua Versus Placebo and Fluticasone Propionate | PHASE3 | COMPLETED | 750 | — | — | Apr 1, 2003 | Jul 1, 2003 | Jan 24, 2011 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Budesonide |
| 2 | ACTIVE_COMPARATOR | Fluticasone propionate |
| 3 | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Budesonide | DRUG | - |
| Fluticasone propionate | DRUG | - |
| Placebo | DRUG | - |
Inclusion Criteria: * At least a 2 year documented history of seasonal allergic rhinitis * who, in the opinion of the investigator, * is a candidate for treatment with nasal steroids based on a history of either * a)inadequate control of symptoms with antihistamines, decongestants and/or immunot...